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Introduction to the Lum bar Fusion Guidelines
As scientific understanding o f the pathophysiology of 
degenerative disease of the lumbar spine has increased, the 
possibilities for correcting the underlying problem and the 
resulting improvement in clinical function have expanded 
exponentially. Fueled by advances in material technology 
and surgical technique, treatment of greater numbers of 
individuals suffering from lumbar spinal disease has prolif­
erated. Using data from the National Hospital Discharge 
Survey, Deyo and colleagues4 described a 200% increase in 
the frequency of lumbar fusion procedures in the 1980s. 
Davis-* observed that the age-adjusted rate of hospitaliza­
tion for lumbar surgery and lumbar fusion increased greater 
than 33% and greater than 60%, respectively, from 1979 
to 1990. Lumbar fusion has been described as a treatment 
of symptomatic degenerative disc disease, spinal stenosis, 
spondylolisthesis, and degenerative scoliosis. Lumbar fu­
sion has been perfonned to treat acute and chronic low- 
back pain, radiculopathy, and spinal instability.
As practitioners have become caught up in the excite­
ment o f what can be accomplished, there are increasing 
questions regarding what should be done and how. These 
questions are being addressed in this current document. 
Guidelines fo r  the Performance o f  Fusion Procedures fo r  
Degenerative Disease o f  the Lumbar Spine.
In January 2003, a group was formed at the request of 
the leadership of the CNS by the executive committee of
Abbreviation used in this paper: CNS = C ongress o f Neurologi­
cal Surgeons.
the American Association of Neurological Surgeons/CNS 
Joint Section on Disorders o f the Spine and Peripheral 
Nerves to perforin an evidence-based review of the litera­
ture on lumbar fusion procedures for degenerative disease 
of the lumbar spine and to formulate treatment recom­
mendations based on this review. In March 2003, this 
group was convened. Invitations were extended to approx­
imately 12 orthopedic and neurosurgical spine surgeons 
active in the Joint Section or in the North American Spine 
Society to ensure participation of nonneurosurgical spine 
surgeons. The 50 recommendations that follow this intro­
duction represent the product o f the work of the group, 
with input from the Guidelines Committee o f the Ameri­
can Association o f Neurological Surgeons/CNS and the 
Clinical Guidelines Committee o f North American Spine 
Society.
The first few papers in this series deal with the meth­
odology of guideline formation and the assessment of 
outcomes following lumbar fusion. The next series of rec­
ommendations involve the diagnostic modalities helpful 
for the pre- and postoperative evaluation o f patients con­
sidered candidates for or treated with lumbar fusion, fol­
lowed by recommendations dealing with specific patient 
populations. Finally, several surgical adjuncts, including 
pedicle screws, intraoperative monitoring, and bone graft 
substitutes are discussed, and recommendations are made 
for their use.
Methodology
The development o f practice parameters, guidelines, or 
recommendations is an onerous and time-consuming pro­
cess. It consists of literature gathering (primarily through
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computerized literature searches), evaluation and classifi­
cation of the quality of evidence provided by the literature, 
interpretation of this evidence to draw meaningful conclu­
sions, and formulation of recommendations based on this 
process. The process is meant to be clear, and the reader is 
encouraged to read the entire document as opposed to the 
recommendations alone.
Guideline development within the specialty of neuro­
surgery has followed a rigorous process delineated early on 
in the advent of specialty-specific guidelines.5 Following 
recommendations proposed by other specialty societies, 
the process used in neurosurgical guideline development 
divides the types of literature into classes depending on the 
scientific strength of the study design.6 Because the publi­
cation of the ground-breaking and exemplary Guidelines 
fo r  the Management o f  Severe Head Injury’,1-2 an e ffort has 
been made to adhere to these strict criteria for practice rec­
ommendations. The definitions of classes of evidence for 
therapeutic effectiveness are as follows: Class 1, evidence 
from one or more well-designed, randomized controlled 
clinical trials, including overviews of such trials; Class 11, 
evidence from one or more well-designed comparative cli­
nical studies, such as nonrandomized cohort studies, case- 
control studies, and other comparable studies, including 
less well-designed randomized controlled trials; and Class 
111, evidence from case series, comparative studies with 
historical controls, case reports, and expert opinion as well 
as significantly flawed randomized controlled trials. For 
diagnostic tests, and clinical assessment, other study de­
signs are used, and therefore the classification systems are 
slightly different, but still result in Classes 1,11, and 111 evi­
dence. This is reviewed in detail elsewhere.6
Class 1 evidence is used to support treatment recom­
mendations of the strongest type, called practice standards, 
reflecting a high degree of clinical certainty. Class 11 evi­
dence is used to support recommendations called guidelines, 
reflecting a moderate degree of clinical certainty. Other 
sources of information, including observational studies such 
as case series and expert opinion, as well as fatally flawed 
randomized controlled trials (Class HI evidence), support 
practice options reflecting unclear clinical certainty.
On the surface, this appears to be a fairly straightfor­
ward task, but within the process the most difficult aspect 
is evaluating the quality of the evidence in each type. 
Disappointingly, studies in which evidence should be con­
sidered Class I or II because of study type have to be 
downgraded to a lower class of evidence due to method­
ological flaws that could cause false conclusions to be 
drawn from the evidence. This is discussed extensively 
within each topic, and all cited evidence is listed in outline 
form in the evidentiary tables, so as to ensure transparen­
cy of the development process.
The group culled through literally thousands of refer­
ences to identify the most scientifically robust citations 
available concerning each individual topic. Not every ref­
erence identified is cited. In general, if high-quality (Class
I or II) medical evidence was available on a particular 
topic, poorer-quality evidence was only briefly summa­
rized and rarely included in the evidentiary tables. If no 
high-quality evidence existed, or if there was significant 
disagreement between similarly classified evidence sourc­
es, then the Class III and supporting medical evidence 
were discussed in greater detail. If multiple reports were
available that provided similar information, a few were 
chosen as illustrative examples.
A consistent finding during the exploration of many of 
these topics was that many investigators reported studies in 
which the designs were unsophisticated. The use of invalid 
outcome measures, the lack of an appropriate power analy­
sis, and the failure to identify distinct patient populations for 
study inhibited our ability to draw meaningful conclusions 
from many reports. Specific examples are provided in the 
text of each topic. Suggestions for future research are made 
at the conclusion of each paper. We, as spine surgeons, must 
improve the quality of our research practices to provide con­
vincing evidence that the therapies we strongly believe in 
are safe, effective, and make economic sense.
During the development of these guidelines, the authors 
often found that their preconceived ideas regarding the 
proper treatment of patients with chronic low-back pain 
were founded on poor-quality or controversial medical evi­
dence. Some recommendations have resulted in changes in 
the authors’ practice patterns after every effort was made to 
classify the evidence and to interpret the results of the vari­
ous studies in a scientifically rigorous fashion. Many rec­
ommendations are made at the lowest level, meaning that 
definitive evidence is lacking to support the recommenda­
tion but that evidence exists at some level. Some readers 
will undoubtedly disagree with one or more of our recom­
mendations or with the level of a given recommendation. 
The justification for all of the recommendations is included 
in the scientific foundation portion and the summary section 
of each guideline. If the job has been done correctly, the rea­
soning behind the recommendation should be clear.
It is our hope, as well as that of the participating orga­
nizations, that these guidelines will help to elucidate the 
current knowledge on the topic of lumbar fusion and will 
stimulate the development of more rigorous scientific evi­
dence justifying or refining— or, if appropriate, eliminat­
ing— aspects of this form of treatment.
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